In the last one month, it has soared over 13 per cent, against a modest three per cent rise in BSE Healthcare index over the same period.
GSK Pharma's recent showing is on expectations that launches in the specialty segment, increasing investments in promotions and branding, foray into new segments and traction for its vaccines business are expected to drive gains.
This coupled with better than expected performance in the March quarter (Q4FY24) led to a 37 per cent rise in the stock price over the last three months. While brokerages expect a turnaround in its base business as well as gains from new launches, this is already factored into valuations. Given the valuations, further gains from these levels for the stock are unlikely.
In the near term, the Street will keep an eye out for growth. The company had posted a doubledigit revenue growth across its key segments of general medicine, specialty and vaccines in the March quarter.
Bu hikaye Business Standard dergisinin June 28, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin June 28, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Women in a shadow war
In the 21st century, many countries have started admitting women into the military in combat roles as fighter pilots and frontline soldiers in grudging recognition of their capabilities and courage.
NCPA-Soho 1st theatrical tie-up blurs boundaries
Indian 'drag kings' to take stage in Mumbai, London in Gentlemen's Club
GAINS AT PUMPS SUPERNORMAL
But low cracks, or profits from processing crude oil into petrol & diesel, have contributed to abysmal refining margins, prompting rethink on lowering retail fuel prices
Everybody wants a 'piece' on Dwarka Expressway
Dwarka Expressway, a 29.1-kilometre (km)-long 16-lane stretch between Shiv Murti in Delhi and Kherki Daula in Gurugram, has become a real estate hotspot, attracting top developers from all over the country announcing their projects in the area.
Accumulate gold through SIP if portfolio allocation below 10%
Gold, which closed at ₹75,447 per 10 gram in the domestic market on Friday (and is trading at ₹2,689.6 per ounce on the Comex), is up 29.4 per cent over the past year.
IT aims for sky after Accenture's Q4 results
Nifty IT index ends 0.4% higher over previous close
NSE, BSE revise transaction fee
Stock exchanges National Stock Exchange (NSE) and BSE on Friday revised their charges for various segments in the market — to align them with the true-to-label circular by the Securities and Exchange Board of India (Sebi) which mandates uniform fee irrespective of the turnover.
GQG Partners settles charges with US SEC
Boutique investment firm GQG Partners has settled charges of potential violations of whistleblower rules with the Securities and Exchange Commission (SEC) — the regulatory body in the United States — by paying a $500,000 penalty.
Sebi plans mandatory disclosures for direct plan MF schemes
The Securities and Exchange Board of India (Sebi) has proposed to make it mandatory for mutual fund houses to give separate disclosures for direct plan and regular plan schemes in their half-yearly financial results.
Crompton Greaves Consumer may underperform on demand concerns
The stock of Crompton Greaves Consumer Electricals has shed about 12 per cent since the start of the month due to a muted near-term outlook.
